Gastid200 ml

Gastid is an antacid-antiflatulent combination used for the short-term relief of gastrointestinal discomfort caused by excess stomach acid and trapped gas.

Established/labeled uses

• Symptomatic relief of dyspepsia (indigestion), heartburn, acid indigestion, and sour stomach
• Hyperacidity associated with peptic ulcer disease, gastritis, and esophagitis
• Gastroesophageal reflux disease (GERD) and hiatal hernia related discomfort (symptom relief only, not disease-modifying)
• Flatulence, bloating, and abdominal distension due to excess gas
• Windy colic in adults

Gastid provides symptomatic relief only; it does not treat the underlying cause of acid-related disease and is not a substitute for evaluation and treatment of persistent or severe symptoms.

Each unit dose of Magaldrate + Simethicone typically contains magaldrate (a hydrated complex of magnesium and aluminum hydroxide, commonly 480 mg) and simethicone (an antiflatulent, commonly 20 mg), formulated as a chewable tablet or oral suspension.

Exact strengths vary by brand and dosage form; check the product label for the specific formulation dispensed.

Gastid is a fixed-dose combination of magaldrate, an antacid that neutralizes gastric acid, and simethicone, an antiflatulent (defoaming agent) that reduces gas-related bloating and discomfort.

It is available as chewable tablets and as an oral suspension, and is used for short-term, on-demand relief of acid indigestion and gas symptoms.

Gastid belongs to the antacid and antiflatulent combination class of gastrointestinal drugs.

Magaldrate + Simethicone combines two complementary mechanisms:

• Magaldrate is a chemical complex of magnesium and aluminum hydroxide. In the acidic environment of the stomach it dissociates and neutralizes hydrochloric acid, raising intragastric pH without producing a marked rebound acid secretion, and does so without excessively alkalinizing the stomach (pH is typically buffered in the 3-5 range), which reduces pepsin activity and relieves acid-related discomfort.
• Simethicone is a surface-active agent that lowers the surface tension of gas bubbles in the gastrointestinal tract, causing small bubbles to coalesce into larger ones that are more easily passed or belched, relieving flatulence and bloating. It acts locally and is not absorbed systemically.

Chew tablets thoroughly before swallowing. Shake the oral suspension well before measuring the dose. Take Gastid 20–60 minutes after meals and at bedtime for best effect, and separate its administration from other oral medicines by at least 2 hours.

Gastid can bind to or alter the absorption of several oral medicines when taken at the same time, reducing their effectiveness. Clinically significant interactions include:

• Tetracycline-class and fluoroquinolone antibiotics (e.g., tetracycline, doxycycline, ciprofloxacin): magnesium and aluminum ions form insoluble chelates with these antibiotics, substantially reducing their absorption and efficacy.
• Digoxin: antacids can reduce digoxin absorption, potentially lowering its therapeutic effect.
• Levothyroxine: absorption may be significantly reduced, risking under-treatment of hypothyroidism.
• Oral iron salts: absorption of iron may be reduced.
• Other drugs such as propranolol, isoniazid, prednisolone, and naproxen may have reduced bioavailability when co-administered.

To avoid these interactions, separate administration of Gastid from other oral medicines by at least 2 hours (or longer for tetracyclines/fluoroquinolones, per product-specific advice), or consult a physician or pharmacist.

Gastid is generally well tolerated when used as directed. Gastrointestinal effects are the most commonly reported and are usually related to the magnesium/aluminum balance:

• Diarrhea (more likely with magnesium-predominant effect)
• Constipation (more likely with aluminum-predominant effect)
• Mild nausea, stomach discomfort, or regurgitation, particularly with excessive doses

Rarely, and mainly with prolonged high-dose use or in patients with renal impairment, symptoms of magnesium or aluminum accumulation (e.g., hypermagnesemia) may occur; see Precautions and Warnings.

Gastid should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus; avoid excessive or prolonged dosing. Consult a physician before use during pregnancy.

Small amounts of the components may pass into breast milk; no significant problems have been commonly reported with occasional use, but a physician should be consulted before use during breastfeeding, particularly with regular or high-dose use.

Use Gastid with caution in the following situations:

• Renal impairment: Patients with reduced kidney function are at risk of accumulating magnesium and aluminum, which can lead to hypermagnesemia, aluminum toxicity, or encephalopathy with prolonged use. Use only under medical supervision in chronic kidney disease.
• Hypophosphatemia: Long-term or high-dose use of aluminum-containing antacids can bind dietary phosphate and cause phosphate depletion, particularly in malnourished patients.
• Elderly and debilitated patients: May be more susceptible to electrolyte disturbances and constipation/diarrhea; monitor closely.
• Drug spacing: Because it can reduce absorption of many oral drugs, separate dosing from other medicines (see Interactions).
• Not for chronic self-medication: If symptoms persist beyond 2 weeks, worsen, or are accompanied by warning signs (e.g., black/bloody stools, unexplained weight loss, difficulty swallowing, persistent vomiting), seek medical evaluation rather than continuing self-treatment.

Overdose with Gastid is uncommon with normal use but excessive or prolonged intake, especially in patients with renal impairment, may cause electrolyte disturbances (hypermagnesemia), diarrhea, or aluminum accumulation. Symptoms may include severe diarrhea, muscle weakness, low blood pressure, or confusion.

If overdose is suspected, seek immediate medical attention or contact a poison control center. Do not attempt specific home treatment without medical guidance.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Renal impairment: Use Gastid with caution and only under medical supervision, due to the risk of magnesium and aluminum accumulation; see Precautions and Warnings.

Hepatic impairment: No well-established dose adjustment is required, but general caution is advised as with any medicine in significant liver disease.

Elderly: May be more prone to electrolyte disturbances and altered bowel habit; use the lowest effective dose.

Children: Safety and efficacy have not been well established; use only under a physician's supervision.

Gastid is intended for short-term, symptomatic, or as-needed use. It should not be used continuously for more than 2 weeks unless directed by a physician. Persistent symptoms warrant medical evaluation.

Antacid + Antiflatulent (gastrointestinal agent combination).

Magaldrate + Simethicone works through two complementary actions: magaldrate chemically neutralizes excess gastric hydrochloric acid, raising intragastric pH and reducing pepsin activity without marked acid rebound, while simethicone physically reduces the surface tension of gas bubbles in the gut so they coalesce and are more easily expelled, relieving bloating and flatulence.

Safety and efficacy of Gastid in children have not been well established through controlled clinical studies. If use is considered necessary in a child, it should only be under the direct guidance and supervision of a physician, with attention to appropriate dose and duration.